Abstract:Objective To analyze predictors of super-response to cardiac resynchronization therapy (CRT) in heart failure patients with reduced ejection fraction and observe the impacts of super-response on cardiac function and prognosis.Methods We retrospectively analyzed consecutive patients who received CRT implantation in our cen ter.Patients were categorized into the super-response and the nonsuper-response group according to the criteria as defined by left ventricular ejection fraction(LVEF)≥0.50 six months after the operation.We used comparison between groups and multivariate Logistic regression analysis to find the independent predictors of super-response to CRT.The impacts of super-response on cardiac structure,function and prognosis were observed through follow-up echocardiography data including LVEF,left ventricular end-diastolic dimension (LVEDD) and left ventricular endsystolic dimension(LVESD) and recorded adverse events.Results Forty-three patients were enrolled,thirteen(30.2 ％)of whom developed super-response.As compared with the control group,there was an increased percentage of nonischemic cardiomyopathy in the super-response group (100％ vs 63.3％,P =0.032).The super-response group also had a shorter course [median course 12 (6-90) months vs 66 (24-108) months,P =0.04] and higher baseline level of LVEF (0.32±0.04 vs 0.27±0.06,P =0.008).Nonischemic etiology (OR =13.580,95 ％CI 1.154-160.055,P=0.038) and baseline level of LVEF ranging from 0.30-0.35 (OR=12.138,95％CI 1.492-80.597,P=0.01) were the independent predictors of super-response after CRT implantation.The improvement in LVEF,LVEDD and LVESD of the super-response group performed significantly better than the nonsuper-response group (P ＜0.001).The rate of composite endpoint events (readmission for heart failure,malignant arrhythmia or all-cause mortality) was lower in the super-response group compared with the control group (15.4 ％ vs 56.7 ％,P =0.012).In the first two years after implantation,the event-free survival rate was significantly higher in super-response patients (log-rank P=0.028).Conclusion Patients with nonischemic cardiomyopathy and relatively higher baseline level of LVEF àre more likely to benefit from CRT implantation and these benefits primarily result from the improvement of cardiac structure and function as well as the decrease in adverse events.

Cardiac Resynchronization Therapy Improves Myocardial Conduction

[Factors Associated with the Efficacy of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure].

Predictors for Cardiac Resynchronization Therapy Response

GW28-e1231 Cardiac Resynchronization Therapy Improves Myocardial Conduction

Comparison of Efficacy of Reverse Remodeling and Clinical Improvement for Relatively Narrow and Wide QRS Complexes after Cardiac Resynchronization Therapy for Heart Failure

Efficacy research of cardiac resynchronization therapy in heart failure with narrow QRS complexes

Reduced Mitral Regurgitation in Heart Failure Patients Submitted to Cardiac Resynchronization Therapy: a Short-Term Prospective Study.

Complete electrical reverse remodeling of native conduction after resynchronization therapies

Value of QRS duration in predicting response to cardiac resynchronization therapy in patients with end-stage heart failure

Predictive Factors and Clinical Effect of Optimized Cardiac Resynchronization Therapy

Initial Experiences of Maintaining Atrioventricular Intrinsic Conduction During Cardiac Resynchronization Therapy in Non-Responders.

Understanding Nonresponders of Cardiac Resynchronization Therapy—Current and Future Perspectives

Ventricular-Arterial Coupling in Patients with Heart Failure Treated with Cardiac Resynchronization Therapy: May We Predict the Long-Term Clinical Response?

Delta QRS and outcomes post CRT in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial

Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography.

[Factors Associated with Efficacy of Cardiac Resynchronization Therapy for Patients with Congestive Heart Failure].

Meta-Analysis of the Usefulness of Change in QRS Width to Predict Response to Cardiac Resynchronization Therapy.

Association of QRS narrowing with response to cardiac resynchronization therapy—a systematic review and meta-analysis of observational studies

Efficacy of Cardiac Resynchronization Therapy for Patients with Refractory Congestive Heart Failure

Predictors of super-response to cardiac resynchronization therapy in heart failure patients with reduced ejection fraction

Comparison of Left Ventricular Reverse Remodeling Induced by Cardiac Contractility Modulation and Cardiac Resynchronization Therapy in Heart Failure Patients with Different Qrs Durations